SCHEMBL2407267

SCHEMBL2407267

CCCNC(=O)c1cccc(-c2cccc(N3CCC(CN(Cc4cscn4)C(=O)O)CC3)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 7/20 0.41
SKP1 P63208 7/20 0.41
SKP2 Q13309 7/20 0.41
PRKD1 Q15139 1/20 0.38
MAP4K4 O95819 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
CNR1 P21554 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
SIRT3 Q9NTG7 1/20 0.35
SYK P43405 2/20 0.35
CAMK2D Q13557 1/20 0.35
ITGAV P06756 1/20 0.35
ITGB6 P18564 1/20 0.35
PKM P14618 1/20 0.34
HTR1A P08908 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2411489 0.94 CKS1B (0.42) CKS1BSKP1SKP2MAP4K4CNR1
SCHEMBL2407113 0.87 SMN1; SMN2 (0.44) CNR1HTR1AHTR2A
SCHEMBL2408111 0.87 PRKD1 (0.37) CKS1BSKP1SKP2PRKD1CNR1
SCHEMBL2405288 0.87 CKS1B (0.41) CKS1BSKP1SKP2MAP4K4CNR1
SCHEMBL2410765 0.84 CNR1 (0.46) CNR1
SCHEMBL2404770 0.84 USP2 (0.36) CKS1BSKP1SKP2KDM4EALDH1A1
SCHEMBL2405635 0.84 PIM2 (0.36) CKS1BSKP1SKP2CNR1
SCHEMBL2406060 0.83 DKK1 (0.42) CNR1
SCHEMBL2406718 0.82 KMO (0.38) CKS1BSKP1SKP2KDM4EALDH1A1
SCHEMBL2405902 0.82 FFAR4 (0.41) CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912218-B2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-12-16 US disclosed
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF MET, ALK, REL CKS1B 2188/4885SKP1 3476/4885SKP2 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.